Bijlagen bij SWD(2014)106 - Actieplan tegen HIV/AIDS in de EU en de buurlanden, 2014-2016 - Hoofdinhoud
Dit is een beperkte versie
U kijkt naar een beperkte versie van dit dossier in de EU Monitor.
dossier | SWD(2014)106 - Actieplan tegen HIV/AIDS in de EU en de buurlanden, 2014-2016. |
---|---|
document | SWD(2014)106 |
datum | 14 maart 2014 |
National
Composite Policy Index
Existence of one national HIV/AIDS plan, including surveillance monitoring and evaluation
Better public awareness on HIV/AIDS
Political
support for the
implementation
of cost-effective, and
evidence based
measures to combat
HIV/AIDS
HIV is
mainstreamed in EU policies
Member States and
neighbouring countries
Civil Society
International organisations
Dissemination and implementation of results from meetings
Actions agreed and implemented
cooperation between all key players
Joint actions carried out
neighbouring countries Civil Society
Commission
discrimination in relation to HIV status, i.e. as monitored by the stigma index
Monitoring of national policies and legislation in place (related to
neighbouring states,
Prohibition of discrimination in relation to HIV status in national legislation
prevention, | HIV-specific | Better quality of life | |||
testing and | discrimination of | of people living with | |||
treatment | People living with | HIV/AIDS | |||
HIV and key | |||||
populations) | Promotion of a | ||||
public health | |||||
Number of actions | approach (as an | ||||
and measures | alternative to | ||||
taken to protect | criminalization) in | ||||
fundamental rights | managing | ||||
including expected | behaviours that put | ||||
results of initiatives | people at risk of HIV | ||||
supported at | acquisition | ||||
international level | |||||
Better awareness of | |||||
legal aspects of | |||||
discrimination | |||||
among Member | |||||
States and | |||||
integrated anti- | |||||
discrimination | |||||
policies with a | |||||
particular focus on | |||||
legislative solutions | |||||
and their correct | |||||
implementation | |||||
HIV/AIDS | Development, | Member States | Ongoing | National European | Scaling up of |
policies and | budgeting | and | -2016 | and international | development and |
strategies | implementation, | neighbouring | AIDS spending by | effective | |
monitoring and | countries | categories and | implementation of | ||
evaluation of | ECDC | financing sources | innovative HIV/AIDS | ||
targeted , | policies at regional, | ||||
regional, national | Civil Society | Number of | national and sub- | ||
and supranational | explicit | national level | |||
HIV/AIDS and co- | International | HIV/AIDS policies | leading to a | ||
infection policies | organisations | in place, scale and | reduction of HIV | ||
quality of | transmission | ||||
implementation | |||||
Sustainability of | |||||
funding for HIV | |||||
and co-infection | |||||
programmes | |||||
Civil society | Support of civil | National | Ongoing | NGOs and | Larger number of |
society through | authorities in the | -2016 | vulnerable groups | effective NGOs in | |
funding and legal | EU and | actively involved in | EU Member States | ||
support at EU and | neighbouring | planning, policy | and neighbouring | ||
national levels in | countries | formulation, | countries | ||
the EU and | budgeting, | ||||
neighbouring | Commission | monitoring | Higher degree of | ||
countries | &evaluation of HIV | NGO participation in | |||
Other | activities at EU, | decision making | |||
Involve and | stakeholders | national and | |||
consult civil | subnational levels | ||||
society including | |||||
people living with | Number of NGOs | ||||
HIV/AIDS and | which have access | ||||
other vulnerable | to specific funding | ||||
groups in | instruments (as a | ||||
development and | result of their |
7
implementation of | participation in | ||||
HIV policies | competitive calls for funding) | ||||
Ensure | |||||
sustainable | Percentage of | ||||
funding | NGOs with | ||||
opportunities for | projected income | ||||
NGOs in relevant | for the next 2/3/5 | ||||
EU instruments | years | ||||
The private | Intensify | Business & | Ongoing | Number of | Successful |
sector | cooperation with the private sector | Industry | -2016 | partnerships programmes | partnership projects |
and invite all | National | between | Solidarity with | ||
relevant | authorities | stakeholders | people living with | ||
stakeholders to | HIV | ||||
develop and | Commission | Number of ARV | |||
implement | price rebate | Affordable and | |||
initiatives | Civil Society | agreements | accessible HIV | ||
addressing | prevention | ||||
HIV/AIDS | measures including | ||||
including in the | condoms | ||||
workplace | Affordable and fair | ||||
Work with | ARV prices | ||||
pharmaceutical | |||||
industry to | Early treatment and | ||||
improve access | care, better | ||||
and availability of | treatment coverage, | ||||
HIV/AIDS | improved health | ||||
treatment across | status of people | ||||
the EU and | living with HIV | ||||
neighbouring | |||||
countries | Development of new business models to facilitate development and access to testing and treatment for HIV and co-infections |
8
2. Prevention | |||||
Targeted and | Identify | National / | Ongoing | Percentage of | Most at risk and |
combination | prevention needs | Regional | -2016 | most at risk groups | general populations, |
prevention | and integrated | authorities | reached with HIV- | and particularly | |
and | strategies based | prevention | young people better | ||
treatment | on current | Civil Society | programmes | informed about HIV | |
evidence and best | prevention | ||||
practice targeted | Commission | Number of health | measures | ||
to sub-national | facilities that | ||||
realities | ECDC | provide HIV testing | Reduction of new | ||
and counselling | HIV infections | ||||
Targeted | 2014- | services | |||
integrated | 2016 | Access to | |||
prevention and | comprehensive and | ||||
treatment to | Funding level of | integrated | |||
most at risk | integrated | prevention, and | |||
groups | prevention and | early testing | |||
(including sex | treatment | services and | |||
workers and | strategies for HIV- | commodities for | |||
prisoners) as | AIDS and co- | most at risk | |||
central focus of | infections including | populations | |||
national HIV- | proportion of | including sex | |||
AIDS and STI | funding targeting | workers and | |||
strategies | Ongoing | most at risk groups | prisoners | ||
-2016 | done in | ||||
Improve | collaboration with | ||||
exchange of best | civil society | ||||
practice, | organisations | ||||
information and | |||||
education on HIV | Number of national | ||||
and HIV | policy documents | ||||
prevention and | and guidelines in | ||||
treatment | which treatment as | ||||
prevention is | |||||
mentioned. | |||||
HIV | Apply evidence | ECDC, | Ongoing | Precise, | Improved |
transmission | based knowledge | -2016 | geographically | understanding of | |
and risk | from behavioural | EMCDDA | distinct | behavioural | |
behaviour | research in order | disaggregated | parameters | ||
to develop | Academia | data and resulting | contributing to the | ||
effective | policies | epidemic | |||
measures leading | Civil Society | ||||
to reduced risk | Number of | Adaptation of | |||
behaviour | Commission | developed | policies and | ||
guidelines and | prevention | ||||
Support the | 2014- | measures leading | measures | ||
enhancing of | 2016 | to reduced risk | |||
treatment | behaviour and | Reduction of new | |||
literacy | increased | HIV cases in most at | |||
treatment uptake | risk populations | ||||
and adherence. | |||||
Percentage of | |||||
health care | |||||
facilities providing | |||||
basic-level HIV | |||||
testing and | |||||
HIV/AIDS clinical | |||||
management |
9
Education | Better | Member States | Ongoing- | Number of | Reduced incidence |
awareness on | 2016 | awareness raising | of HIV and sexually | ||
sexual and | International | actions carried out | transmitted | ||
reproductive | Organisations | infections in | |||
health | particular among | ||||
Civil Society | young people | ||||
Commission | Less stigma and | ||||
discrimination of | |||||
groups at risk of HIV | |||||
and sexually | |||||
transmitted | |||||
infections | |||||
3. Priority regions and settings | |||||
Eastern | Reach universal | National | Ongoing | Domestic and | More people under |
European | access to | authorities | -2016 | international | treatment, decline of |
Member | voluntary testing, | HIV/AIDS | AIDS related deaths | ||
States, | treatment and | Civil society | spending | ||
Enlargement, | care | (including harm | Reduction of HIV | ||
ENP | Regional (Health) | reduction | and co-infections | ||
countries and | Introduction and | Networks (i.e. | measures) by | infection rate among | |
the Russian | implementation of | Northern | categories, | injecting drug users | |
Federation | effective harm | Dimension | financing source, | ||
reduction | Partnership in | and allocation to | Better health status | ||
measures for | Public Health and | priority groups. | of IDUs and | ||
prevention of HIV | Social Wellbeing) | prisoners and their | |||
and co-infections | Number of basic | partners | |||
Commission | activities and | ||||
Prevention and | programmes in | Decreased HIV and | |||
integrated HIV, | place, scale and | co-infections | |||
and co-infections | quality of | incidence in prisons | |||
treatment, | implementation, | ||||
including in | synergies | ||||
prisons and other | developed and | ||||
particular settings, | critical enablers | ||||
using innovative | funded | ||||
strategies to | |||||
reach target | Coverage of | ||||
groups, | integrated | ||||
particularly MSM, | prevention and | ||||
IDUs and Sex | treatment services | ||||
Workers | in prisons | ||||
Provision of | |||||
integrated HIV and | |||||
co-infections | |||||
services | |||||
Enlargement, | Promote | Commission | Ongoing | HIV/AIDS and co- | Improved national |
ENP | Cooperation on | -2016 | infections as an | HIV/AIDS and co- | |
countries and | HIV/AIDS and co- | Member States | agenda point in | infections plans for | |
the Russian | infections | and | regular health | prevention, | |
Federation | between the | neighbouring | policy dialogues | treatment, care and | |
EU, and | countries | with relevant | support | ||
neighbouring | Enlargement, | ||||
countries through | WHO | ENP countries, | Effective | ||
established policy | and the Russian | implementation of | |||
dialogue | UNAIDS | Federation | antidiscrimination | ||
mechanisms | policies | ||||
ECDC | Alignment of | ||||
Invitation and | actions with |
10
involvement of | international | |||
neighbouring | organizations | |||
countries in HIV | working on HIV- | |||
related meetings | AIDS to generate | |||
at EU level | synergies and | |||
maximize impact | ||||
Monitoring and | 2014- | |||
reporting | 2016 | Number of | ||
progress in | Enlargement and | |||
implementation | ENP annual | |||
of HIV-related | progress reports | |||
actions agreed | addressing | |||
in bilateral | HIV/AIDS and co- | |||
cooperation | infections | |||
agreements | ||||
and/or Action | ||||
Plans between | ||||
the EU and | ||||
neighbouring | ||||
countries | ||||
Strengthen the | ECDC, WHO- | Ongoing | Increased | Better surveillance, |
surveillance by | Euro, EMCDDA, | -2016 | interaction with | monitoring and |
stepping up | and involvement of | evaluation | ||
cooperation | Surveillance | Enlargement and | ||
between the | institutions in | ENP countries in | Improved integrated | |
ECDC, WHO- | Neighbouring | ECDC HIV/AIDS | HIV policies and | |
Euro, EMCDDA | countries and | and co-infection | programmes in the | |
and surveillance | Russian | programmes | EU and | |
authorities in | Federation | neighbouring | ||
Enlargement and | countries | |||
ENP countries | Commission | |||
and Russian | ||||
Federation | ENP partners | |||
Member States | ||||
Civil society | ||||
Exchange | Health | Ongoing | Number of | Better trained clinical |
programmes | Professional | -2016 | exchange | and social staff and |
between Member | associations | programmes | NGOs | |
States and | ||||
neighbouring | Member States | |||
countries for | ||||
training of medical | Neighbouring | |||
and social and | countries | |||
NGO staff | ||||
Civil Society | ||||
Industry |
11
4. Priority groups | |||||
Men having | Intensify the | Civil Society | Ongoing- | HIV incidence and | Adaptation in risk |
sex | promotion of safer | 2016 | prevalence | behaviour | |
with men | sex behaviour among MSM | Member States | among MSM | Reduction in HIV | |
Information on | Neighbouring | Changes | transmission among | ||
HIV prevention | countries | (increase/decreas | MSM | ||
integrated in | e) in rates of | ||||
sexual and | Commission | unsafe sex | Less stigma and | ||
reproductive | practices amongst | discrimination | |||
health education | ECDC | MSM | |||
and health care | Better knowledge on | ||||
services | sexual and reproductive health | ||||
Intensify | Member | Ongoing | Rate of late | Decrease of late | |
implementation of | States | -2016 | diagnoses among | diagnoses, timely | |
voluntary | MSM | start of treatment | |||
counselling and | Neighbouring | ||||
testing programs | countries | HIV testing rates | Reduction in HIV | ||
(VCT) among | among MSM | transmission among | |||
MSM | Health | MSM | |||
and other most at | Professional | Rate of unknown | |||
risk groups at | Associations | HIV status | |||
healthcare, and | and community | ||||
community based | based | Percentage of | |||
facilities, ensuring | organisations | MSM who | |||
effective link to | received an HIV | ||||
treatment and | Commission | test in the last 12 | |||
care | Civil Society | months and who know their results | |||
Increase | |||||
innovative testing | Percentage of | ||||
strategies | MSM reached | ||||
including outreach | with HIV | ||||
and peer support | programmes | ||||
to ensure access | |||||
to voluntary | |||||
counselling and | |||||
testing to most at | |||||
risk groups | |||||
Injecting drug | Implementation of | Member States | Ongoing | Coverage of harm | Decreased HIV |
users (IDUs) | risk and harm | -2016 | reduction | incidence among | |
reduction | Neighbouring | programmes, | people who inject | ||
measures to IDUs | countries | including syringe | drugs | ||
and their partners | exchange and | ||||
for prevention and | Civil Society | clean needles | Better access for | ||
treatment of HIV, | IDUs to harm | ||||
co-infections and | Commission | Coverage of drug | reduction measures, | ||
drug dependency | substitution, HIV | including clean | |||
in the community | ECDC | and co-infections | syringes and needles | ||
and prisons | treatment programmes Percentage of IDUs reached with HIV | Availability of specific, effective prevention programmes for IDUs and their |
12
programmes | partners | ||||
Migrants and | Targeted | Migrants and | Ongoing | Number of | Better information of |
mobile | prevention | ethnic minorities | -2016 | programmes and | migrants on risk |
populations7 | measures and | organisations | policies | prevention, HIV/AIDS | |
access to | developed and | and treatment, care | |||
services and | National | implemented | and support | ||
treatment for | authorities | ||||
migrants, and | Coverage of | Improved access and | |||
mobile | Commission | prevention | information on rights | ||
populations | services and | and possibilities for | |||
Civil society | treatment for | migrants and mobile | |||
Sustain and | 2014- | migrants, | population | ||
promote testing | 2016 | including | |||
and treatment | undocumented | ||||
migrants, and | |||||
mobile | |||||
populations | |||||
Abolish HIV | National | Ongoing | Number of | Non-discrimination of | |
associated travel | authorities | -2016 | countries/regions | migrants and mobile | |
and residence | with restrictions | populations with | |||
restrictions | regard to HIV status | ||||
5. Improving the knowledge | |||||
Research | Promote research | Commission | Ongoing- | Projects and | Moving towards a |
for the | 2016 | programmes | cure and | ||
development of | Member States | funded | development of new | ||
new, or better | or better diagnostic | ||||
prevention, | Industry | and preventive tools | |||
diagnostic and | and treatment | ||||
treatment | Research | options | |||
solutions for HIV, | institutions | ||||
co-infections and | |||||
co-morbidity | Public health | ||||
Institutions | |||||
Civil Society | |||||
In depth analysis | ECDC | 2014- | Studies, reports, | More adequate, | |
of trends and | 2016 | recommendations | evidence based | ||
dynamics in | EMCDDA | prevention | |||
sexual and drug | Number of actions | programmes, in | |||
use related risk | Academia | funded under EU | particular for risk | ||
behaviour | programmes | populations | |||
Commission | |||||
Ensure adequate | |||||
allocation of | Member States | ||||
funding for social | |||||
and behavioural | Civil society |
7 By "migrants" we understand third-country nationals. By "mobile populations" we understand EU citizens exercising their right to free movement. It also include ethnic minorities defined as, national minorities, in line with the Charter of Fundamental Rights prohibiting discrimination on any ground, such as sex, race, colour, ethnic or social origin, etc. http://ec.europa.eu/justice/fundamental-rights/minorities/index_en.htm.
13
research, socio- | ||||||
economic | ||||||
analysis | ||||||
Health care | Improve | Health | Ongoing- | Broad application | Timely diagnosis and | |
capacities and | professionals | 2016 | of international | more effective | ||
knowledge of | associations and | testing and | treatment solutions | |||
medical staff and | community | treatment | ||||
community based | based | guidelines | ||||
organisations with | organisations | |||||
regards to | ||||||
HIV/AIDS and co- | Member States | |||||
infections | ||||||
prevention, | WHO | |||||
testing, treatment | ||||||
and care including | Academia | |||||
larger | ||||||
dissemination of | Industry | |||||
clinical best | ||||||
practice | ||||||
Surveillance | Enhanced and | ECDC | Ongoing- | Comprehensive | Powerful | |
integrated | 2016 | overview of | epidemiology | |||
surveillance of all | EMCDDA | HIV/AIDS and co- | resulting in | |||
relevant aspects | infections in the | comprehensive and | ||||
on HIV/AIDS and | WHO | European region | evidence based | |||
CO | - infections | disaggregated | policies | |||
(including | Commission | data to identify | ||||
strengthened bio- | epidemiology | |||||
behavioural | Member States | including those | ||||
surveillance) | and neighbouring | linked to | ||||
countries | behavioural | |||||
issues | ||||||
Civil society | ||||||
6. Monitoring and | ||||||
evaluation | ||||||
Commitments of | Regular | ECDC | Ongoing | Progress reports | Realisation of | |
Dublin, Vilnius | monitoring | (Every 2 | commitments | |||
and Bremen | on scale and | WHO | years) | |||
declarations | quality | Improved quality of | ||||
of | Commission | life of people living | ||||
implementatio | and affected by HIV | |||||
n | UNAIDS | |||||
Reduced incidence | ||||||
Civil Society | ||||||
Member | ||||||
States and | ||||||
neighbouring | ||||||
countries | ||||||
Implementation | On-going | ECDC | Ongoing- | Progress reports | More effective | |
of this action | monitoring on | 2016 | policies, less new | |||
plan | scale and | Commission | HIV infections, better | |||
quality of | medical, social and | |||||
implementatio | Think Tank | legal conditions for | ||||
n | people affected by | |||||
HIV/AIDS Civil | HIV | |||||
Society Forum |
14